A carregar...
TSH-Based Protocol, Tablet Instability, and Absorption Effects on L-T(4) Bioequivalence
BACKGROUND: FDA Guidance for pharmacokinetic (PK) testing of levothyroxine (L-T(4)) for interbrand bioequivalence has evolved recently. Concerns remain about efficacy and safety of the current protocol, based on PK analysis following supraphysiological L-T(4) dosing in euthyroid volunteers, and rece...
Na minha lista:
Main Authors: | , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Mary Ann Liebert, Inc.
2009
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2858298/ https://ncbi.nlm.nih.gov/pubmed/19191742 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/thy.2008.0148 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|